Free
![COPDPredict](https://is1-ssl.mzstatic.com/image/thumb/Purple122/v4/88/39/54/88395455-1e2f-915c-4f88-dad81318a58c/AppIcon-0-0-1x_U007emarketing-0-0-0-7-0-0-sRGB-0-0-0-GLES2_U002c0-512MB-85-220-0-0.png/100x0w.png)
COPDPredict
Exacerbation Prediction
⭐️0 / 5
Rating
🙌0
Ratings
📼10 scs
Content
📦w/o updates
Updates frequency
🗣❌ unsupported
Your locale
- Versions
- Price History
- Description
- FAQ
All Versions of COPDPredict
4.1
October 4, 2022
Update bug Fix
3.10
October 4, 2022
Bugs Fixes
3.9
September 23, 2022
Add Assessments Validations
Bug fixes
3.6
December 27, 2021
Bug Fixes
3.5
December 7, 2021
Bugs Fixes
3.4
March 18, 2021
MIR Updates
Bug Fixes
3.1
August 14, 2020
Bug fixes
3.0
August 8, 2020
UI Changes
Bug fixes
Add Medical References
1.0
August 4, 2020
Price History of COPDPredict
Description of COPDPredict
COPDPredict is a CE-marked smart digital monitoring solution from NEPeSMO that allows individuals living with chronic obstructive airways disease (COPD) and their healthcare team to predict the onset of exacerbations (otherwise known as acute episodes or flare-ups) and prompt early intervention, thus preventing unnecessary emergency department visits and hospitalisations.
COPDPredict™ is for use by individuals with a diagnosis of COPD with greater than or equal to 1 acute exacerbation of their COPD per year.
COPDPredict™ allows you to input, collect, log and track trend data from blue-tooth connected suitable devices such as lung monitors in a home setting to share with a healthcare provider by sending data to a secure clinician-facing website.
COPDPredict™ uses a combination of your-reported wellbeing scores, lung function and biomarker levels to generate your own personal health profile. Exacerbation prediction algorithms determine the potential risk of an exacerbation of COPD based on your data inputs. Your healthcare team can then provide you with the tailored support and intervention you require closer to home. You can also communicate regularly and securely with your healthcare team using the within-App messaging facility.
In addition, COPDPredict™ offers you a suite of digital educational material on healthy living, inhaler technique and pulmonary rehabilitation to help you self-manage your COPD and remain in control.
COPDPredict™ is registered with MHRA and is OWASP and DSP toolkit compliant.
NEPeSMO is a UK-registered healthcare technology company founded by respiratory physicians who have worked with patients and clinicians to develop and deliver smart user-friendly self-monitoring solutions for personalised respiratory care and treatment.
At the moment NEPeSMO interacts directly with healthcare providers to offer the COPDPredict™ service under a software-as-a-service agreement. If you are an individual living with COPD and experience exacerbations of COPD and wish to use COPDPredict, you can only do this if your healthcare team has signed up to our services and has registered you as a patient.
Please do contact us for further information on info@nepesmo.com or visit our website www.nepesmo.com where you can view what COPDPredict™ does and how it works.
Show less
COPDPredict: FAQ
Yes, COPDPredict offers an iPad version.
NEPESMO LTD is the developer of the app.
The COPDPredict app currently supports iOS 12.0 or later.
There is no information available about user ratings for COPDPredict.
The App Genre Of The Copdpredict App Is Medical.
The latest COPDPredict version released is 4.1.
The latest COPDPredict app update was released on July 8, 2024.
COPDPredict was first made available on February 5, 2023.
This app is rated for ages 17 and up, and contains mature themes or intense violence.
COPDPredict is now available to use in English.
Sorry, COPDPredict is not part of Apple Arcade.
No, COPDPredict is not eligible for in-app purchases.
Unfortunately, COPDPredict is not fully compatible with Apple Vision Pro.